Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Ixovex-1 |
Synonyms | |
Therapy Description |
Ixovex-1 is a recombinant oncolytic adenovirus with a mutation in the E1B region resulting in overexpression of the E1B-156R splice isoform, which potentially inhibits tumor growth (PMID: 35596069). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Ixovex-1 | Ixovex|Ixovex1|Ixovex 1 | Ixovex-1 is a recombinant oncolytic adenovirus with a mutation in the E1B region resulting in overexpression of the E1B-156R splice isoform, which potentially inhibits tumor growth (PMID: 35596069). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06549946 | Phase Ib/II | Ixovex-1 Ixovex-1 + Pembrolizumab | Ixovex-1 Single Agent and Combination Therapy (IXACT) | Recruiting | GBR | 0 |